The Sarah W. Stedman Nutrition and Metabolism Center at Duke has developed a research-dedicated Metabolomics core laboratory that conducts metabolic, endocrine, inflammatory marker, and physiologic profiling of cultured cells, as well as tissue and bodily fluid samples from animal models and human subjects. Its role in the current program will be to provide both targeted and non-targeted mass spectrometry (MS)- based metabolic profiling assays in tissue and blood fluid samples for all of the projects. The core will also provide key assays of peptide hormones such as IGF-1, IGF-1 binding proteins, growth hormone, and leptin for Project 1, as well as insulin and glucose measurements to support Project 4. The core will also develop or refine novel metabolomics technologies relevant to this program, including development of new chromatography methods for resolving isobaric metabolites such as leucine and isoleucine in MS assays, targeted assays for distal metabolites in the BCAA and Tyr/Phe catabolic pathways, and refinement of non- targeted GC/MS-based metabolic profiling methods. Participation of this core in the program is highly significant because it provides powerful capabilities for detecting changes in metabolite levels in multiple tissues and bodily fluids in response to genetic and dietary manipulations, thereby providing insights into key mechanisms underlying development of insulin resistance and type 2 diabetes.
(See Instructions): Participation of this core in the program is highly relevant because it provides powerful capabilities for detecting changes in metabolite levels in multiple tissues and bodily fluids in response to genetic and dietary manipulations, thereby providing insights into key mechanisms underlying development of insulin resistance and type 2 diabetes.
|Shantavasinkul, Prapimporn Chattranukulchai; Muehlbauer, Michael J; Bain, James R et al. (2018) Improvement in insulin resistance after gastric bypass surgery is correlated with a decline in plasma 2-hydroxybutyric acid. Surg Obes Relat Dis 14:1126-1132|
|McGarrah, Robert W; Crown, Scott B; Zhang, Guo-Fang et al. (2018) Cardiovascular Metabolomics. Circ Res 122:1238-1258|
|Fisher-Wellman, Kelsey H; Davidson, Michael T; Narowski, Tara M et al. (2018) Mitochondrial Diagnostics: A Multiplexed Assay Platform for Comprehensive Assessment of Mitochondrial Energy Fluxes. Cell Rep 24:3593-3606.e10|
|Jin, Eunsook S; Lee, Min Hee; Murphy, Rebecca E et al. (2018) Pentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver. Am J Physiol Endocrinol Metab 314:E543-E551|
|Ren, Jimin; Shang, Ty; Sherry, A Dean et al. (2018) Unveiling a hidden 31 P signal coresonating with extracellular inorganic phosphate by outer-volume-suppression and localized 31 P MRS in the human brain at 7T. Magn Reson Med 80:1289-1297|
|An, Jie; Wang, Liping; Patnode, Michael L et al. (2018) Physiological mechanisms of sustained fumagillin-induced weight loss. JCI Insight 3:|
|Peterson, Brett S; Campbell, Jonathan E; Ilkayeva, Olga et al. (2018) Remodeling of the Acetylproteome by SIRT3 Manipulation Fails to Affect Insulin Secretion or ? Cell Metabolism in the Absence of Overnutrition. Cell Rep 24:209-223.e6|
|White, Phillip J; McGarrah, Robert W; Grimsrud, Paul A et al. (2018) The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. Cell Metab 27:1281-1293.e7|
|Jin, Eunsook S; Browning, Jeffrey D; Murphy, Rebecca E et al. (2018) Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans. J Lipid Res 59:1685-1694|
|Newgard, Christopher B (2017) Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab 25:43-56|
Showing the most recent 10 out of 181 publications